ArticleFrontiers in endocrinology2026
Triglyceride-glucose index and nocturnal oxygenation impairment in patients with obstructive sleep apnea.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In obstructive sleep apnea (OSA), respiratory events differ not only in frequency but also in the depth and duration of oxygen desaturation. The triglyceride-glucose (TyG) index is a routinely available marker related to insulin resistance, but its relationship with conventional nocturnal oxygenation-related parameters in OSA remains incompletely clarified. Objective: We examined the association of the TyG index with hypoxemia-related sleep parameters and explored whether these associations were influenced by monitoring modality and AHI-defined OSA severity. Methods: This single-center retrospective cross-sectional study screened 154 consecutive symptomatic adult inpatients from 2021 to 2025; after exclusion of 11 patients, 143 were included in the retrospective dataset. Diagnostic sleep monitoring was performed using in-laboratory polysomnography or Nox T3 portable monitoring. Laboratory measurements were obtained within 3 days before or after sleep monitoring. Severe nocturnal oxygen desaturation was defined as lowest SpO Results: TyG was available in 116 patients, and 101 had complete TyG, lowest SpO Conclusion: Higher TyG was associated with worse nocturnal oxygenation-related parameters and greater AHI-defined OSA severity, but these exploratory findings may partly reflect overall OSA severity. TyG may provide a simple metabolic clue for risk stratification, but it cannot replace formal sleep monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.